Relay Therapeutics, Inc. (RLAY) Earnings
|
Expand Research on RLAY
| Next EPS Date | 11/11/26 | EPS Growth Rate | +7.0% |
|---|---|---|---|
| Average EPS % Beat Rate | +5.1% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -3.8% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | -$0.40 | N/A | N/A | $1.67M | N/A | N/A | N/A | ||
| 8/6/26 | Q226 | -$0.41 | -$0.39 | -$0.02 | $400K | $733.33K | N/A |  | | Details | |
| 5/5/26 |
Q126 | N/A | -$0.36 | N/A | N/A | $4.23M | N/A | N/A | N/A | ||
| 5/1/26 |
Q126 | N/A | -$0.36 | N/A | N/A | $4.23M | N/A | N/A | N/A | ||
| 4/30/26 |
Q126 | N/A | -$0.36 | N/A | N/A | $4.23M | N/A | N/A | N/A | ||
| 2/26/26 |
Q425 | N/A | -$0.41 | N/A | N/A | $6.39M | N/A | N/A | N/A | ||
| 2/19/26 |
Q425 | N/A | -$0.41 | N/A | N/A | $6.39M | N/A | N/A | N/A | ||
| 11/6/25 | Q325 | -$0.43 | -$0.42 | -$0.01 | N/A | $182.86K | N/A | | | Details |
